VXRT
Vaxart Inc (VXRT)
$1.03
Market is closedMarket is closed – opens on 8 PM, 12 Dec 2022
– opens on 8 PM, 12 Dec 2022
Key Stats
$1.02
Day's Range
$1.16
$1.02
52-Week Range
$7.61
| Returns | |
| 1 month return | 33.55% |
| 3 month return | 64.36% |
| 1 year return | 83.44% |
| 5 year return | 76.22% |
Company Information
Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using tablets that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart has believes that its proprietary tablet vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Its development programs currently include tablet vaccines designed to protect against coronavirus, Norovirus, seasonal influenza and respiratory syncytial virus (RSV), as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart's first immuno-oncology indication. Vaxart has filed broad domestic and international patents covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.
| Organization | Vaxart Inc |
| Employees | 110 |
| CEO | Mr. Cezar Andrei Floroiu M.B.A. |
| Industry | Health Technology |
Analyst Recommendation
based on 5 analysts ratings
Buy
80%
Buy
20%
Hold
0%
Sell
Based on 5 Wall street analysts offering stock ratings for Vaxart Inc(by analysts ranked 0 to 5 stars)
Analyst Forecast
What analysts predicted
Upside of 652.43%Current
$1.03
Target
$7.75
Recommendation Trend
Based on 5 analyst
| Current | 1M Ago | 3M Ago | |
| Buy | 4 | 8 | 9 |
| Hold | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 |
| Consensus | BUY | BUY | BUY |
Highlights
| Market Capitalization | 149.6M |
| Book Value | $0.95 |
| Dividend Share | 0.0 |
| Dividend Yield | 0.0% |
| Earnings Per Share (EPS) | -0.64 |
| Wall Street Target Price | 7.75 |
Valuation
| Trailing PE | 0.0 |
| Forward PE | 42.74 |
| Price/Book (mrq) | 1.26 |
| Enterprise Value | 78.0M |
| Enterprise Value/Revenue | 490.72 |
| Enterprise Value/Ebitda | -0.8 |
Technicals
| Beta | 0.68 |
| 50 Day MA | 1.58 |
| 200 Day MA | 3.27 |
Institutional Holdings
State Street Corporation
10.72%
BlackRock Inc
6.94%
Vanguard Group Inc
5.32%
Geode Capital Management, LLC
1.7%
Goldman Sachs Group Inc
1.04%
Northern Trust Corp
0.87%
Discover more
Frequently Asked Questions
What is Vaxart Inc share price today?
Can Indians buy Vaxart Inc shares?
How can I buy Vaxart Inc shares from India?
Can Fractional shares of Vaxart Inc be purchased?
What are the documents required to start investing in Vaxart Inc stocks?
What are today’s High and Low prices of Vaxart Inc?
What are today’s traded volumes of Vaxart Inc?
What is today’s market capitalisation of Vaxart Inc?
What is the 52 Week High and Low Range of Vaxart Inc?
How much percentage Vaxart Inc is down from its 52 Week High?
How much percentage Vaxart Inc is up from its 52 Week low?
What are the historical returns of Vaxart Inc?
Who is the Chief Executive Officer (CEO) of Vaxart Inc?
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*